The dual role of fibulins in tumorigenesis

Cancer Letters

Volumn 325, Issue 2, 2012, Pages 132-138

  Obaya, Alvaro J ^a   Rua, Susana ^b   Moncada Pazos, Angela ^b   Cal, Santiago ^b  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

Elastogenesis; Epigenetic silencing; Extracellular matrix; Metalloprotease; Mouse model

Indexed keywords

ADAMTS1 PROTEIN; FIBULIN; FIBULIN 1; FIBULIN 2; FIBULIN 3; FIBULIN 4; FIBULIN 5; FIBULIN 6; FIBULIN 7; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CARCINOGENESIS; CONNECTIVE TISSUE; EFEMP1 GENE; EFEMP2 GENE; ELASTIC FIBER; EXTRACELLULAR MATRIX; FBLN1 GENE; FBLN2 GENE; FBLN5 GENE; FBLN6 GENE; FBLN7 GENE; FIBER; HMCN1 GENE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SHORT SURVEY; STROMA CELL; TUMOR GENE; TUMOR GROWTH;

EID: 84865633993     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.06.019     Document Type: Review

References (85)

1. de Vega S., Iwamoto T., Yamada Y. Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol. Life Sci. 2009, 66:1890-1902.
2. Kobayashi N., Kostka G., Garbe J.H., Keene D.R., Bachinger H.P., Hanisch F.G., Markova D., Tsuda T., Timpl R., Chu M.L., Sasaki T. A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization. J. Biol. Chem. 2007, 282:11805-11816.
3. Vogel B.E., Hedgecock E.M. Hemicentin, a conserved extracellular member of the immunoglobulin superfamily, organizes epithelial and other cell attachments into oriented line-shaped junctions. Development 2001, 128:883-894.
4. Carpten J.D., Makalowska I., Robbins C.M., Scott N., Sood R., Connors T.D., Bonner T.I., Smith J.R., Faruque M.U., Stephan D.A., Pinkett H., Morgenbesser S.D., Su K., Graham C., Gregory S.G., Williams H., McDonald L., Baxevanis A.D., Klingler K.W., Landes G.M., Trent J.M. A 6-Mb high-resolution physical and transcription map encompassing the hereditary prostate cancer 1 (HPC1) region. Genomics 2000, 64:1-14.
5. de Vega S., Iwamoto T., Nakamura T., Hozumi K., McKnight D.A., Fisher L.W., Fukumoto S., Yamada Y. TM14 is a new member of the fibulin family (fibulin-7) that interacts with extracellular matrix molecules and is active for cell binding. J. Biol. Chem. 2007, 282:30878-30888.
6. Segade F. Molecular evolution of the fibulins: implications on the functionality of the elastic fibulins. Gene 2010, 464:17-31.
7. Wagenseil J.E., Mecham R.P. New insights into elastic fiber assembly. Birth Defects Res. C Embryo Today 2007, 81:229-240.
8. Wagenseil J.E., Mecham R.P. Vascular extracellular matrix and arterial mechanics. Physiol. Rev. 2009, 89:957-989.
9. Kielty C.M., Sherratt M.J., Shuttleworth C.A. Elastic fibres. J. Cell Sci. 2002, 115:2817-2828.
10. Roark E.F., Keene D.R., Haudenschild C.C., Godyna S., Little C.D., Argraves W.S. The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J. Histochem. Cytochem. 1995, 43:401-411.
11. Nakamura T., Lozano P.R., Ikeda Y., Iwanaga Y., Hinek A., Minamisawa S., Cheng C.F., Kobuke K., Dalton N., Takada Y., Tashiro K., Ross J., Honjo T., Chien K.R. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 2002, 415:171-175.
12. Argraves W.S., Greene L.M., Cooley M.A., Gallagher W.M. Fibulins: physiological and disease perspectives. EMBO Rep. 2003, 4:1127-1131.
13. Yanagisawa H., Davis E.C. Unraveling the mechanism of elastic fiber assembly: the roles of short fibulins. Int. J. Biochem. Cell Biol. 2010, 42:1084-1093.
14. Vukovic J., Ruitenberg M.J., Roet K., Franssen E., Arulpragasam A., Sasaki T., Verhaagen J., Harvey A.R., Busfield S.J., Plant G.W. The glycoprotein fibulin-3 regulates morphology and motility of olfactory ensheathing cells in vitro. Glia 2009, 57:424-443.
15. Xiang Y., Sekine T., Nakamura H., Imajoh-Ohmi S., Fukuda H., Yudoh K., Masuko-Hongo K., Nishioka K., Kato T. Fibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritis. J. Immunol. 2006, 176:3196-3204.
16. Vogel B.E., Muriel J.M., Dong C., Xu X. Hemicentins: what have we learned from worms?. Cell Res. 2006, 16:872-878.
17. Kostka G., Giltay R., Bloch W., Addicks K., Timpl R., Fassler R., Chu M.L. Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice. Mol. Cell Biol. 2001, 21:7025-7034.
18. Sicot F.X., Tsuda T., Markova D., Klement J.F., Arita M., Zhang R.Z., Pan T.C., Mecham R.P., Birk D.E., Chu M.L. Fibulin-2 is dispensable for mouse development and elastic fiber formation. Mol. Cell Biol. 2008, 28:1061-1067.
19. McLaughlin P.J., Bakall B., Choi J., Liu Z., Sasaki T., Davis E.C., Marmorstein A.D., Marmorstein L.Y. Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice. Hum. Mol. Genet. 2007, 16:3059-3070.
20. McLaughlin P.J., Chen Q., Horiguchi M., Starcher B.C., Stanton J.B., Broekelmann T.J., Marmorstein A.D., McKay B., Mecham R., Nakamura T., Marmorstein L.Y. Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice. Mol. Cell Biol. 2006, 26:1700-1709.
21. Yanagisawa H., Davis E.C., Starcher B.C., Ouchi T., Yanagisawa M., Richardson J.A., Olson E.N. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 2002, 415:168-171.
22. Gallagher W.M., Currid C.A., Whelan L.C. Fibulins and cancer: friend or foe?. Trends Mol. Med. 2005, 11:336-340.
23. Law E.W., Cheung A.K., Kashuba V.I., Pavlova T.V., Zabarovsky E.R., Lung H.L., Cheng Y., Chua D., Lai-Wan Kwong D., Tsao S.W., Sasaki T., Stanbridge E.J., Lung M.L. Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, fibulin-2, in nasopharyngeal carcinoma. Oncogene 2012, 31:728-738.
24. Kim E.J., Lee S.Y., Woo M.K., Choi S.I., Kim T.R., Kim M.J., Kim K.C., Cho E.W., Kim I.G. Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation. Int. J. Oncol. 2012, 40:402-408.
25. Yue W., Sun Q., Landreneau R., Wu C., Siegfried J.M., Yu J., Zhang L. Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression. Cancer Res. 2009, 69:6339-6346.
26. Timpl R., Sasaki T., Kostka G., Chu M.L. Fibulins: a versatile family of extracellular matrix proteins. Nat. Rev. Mol. Cell Biol. 2003, 4:479-489.
27. Twal W.O., Czirok A., Hegedus B., Knaak C., Chintalapudi M.R., Okagawa H., Sugi Y., Argraves W.S. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J. Cell Sci. 2001, 114:4587-4598.
28. Moll F., Katsaros D., Lazennec G., Hellio N., Roger P., Giacalone P.L., Chalbos D., Maudelonde T., Rochefort H., Pujol P. Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 2002, 21:1097-1107.
29. Roger P., Pujol P., Lucas A., Baldet P., Rochefort H. Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human ovarian epithelial tumors. Am. J. Pathol. 1998, 153:1579-1588.
30. Pupa S.M., Argraves W.S., Forti S., Casalini P., Berno V., Agresti R., Aiello P., Invernizzi A., Baldassari P., Twal W.O., Mortarini R., Anichini A., Menard S. Immunological and pathobiological roles of fibulin-1 in breast cancer. Oncogene 2004, 23:2153-2160.
31. Forti S., Scanlan M.J., Invernizzi A., Castiglioni F., Pupa S., Agresti R., Fontanelli R., Morelli D., Old L.J., Pupa S.M., Menard S. Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum. Breast Cancer Res. Treat. 2002, 73:245-256.
32. Greene L.M., Twal W.O., Duffy M.J., McDermott E.W., Hill A.D., O'Higgins N.J., McCann A.H., Dervan P.A., Argraves W.S., Gallagher W.M. Elevated expression and altered processing of fibulin-1 protein in human breast cancer. Br. J. Cancer 2003, 88:871-878.
33. Sadlonova A., Bowe D.B., Novak Z., Mukherjee S., Duncan V.E., Page G.P., Frost A.R. Identification of molecular distinctions between normal breast-associated fibroblasts and breast cancer-associated fibroblasts. Cancer Microenviron. 2009, 2:9-21.
34. Bardin A., Moll F., Margueron R., Delfour C., Chu M.L., Maudelonde T., Cavailles V., Pujol P. Transcriptional and posttranscriptional regulation of fibulin-1 by estrogens leads to differential induction of messenger ribonucleic acid variants in ovarian and breast cancer cells. Endocrinology 2005, 146:760-768.
35. Qing J., Maher V.M., Tran H., Argraves W.S., Dunstan R.W., McCormick J.J. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines. Oncogene 1997, 15:2159-2168.
36. Cheng Y.Y., Jin H., Liu X., Siu J.M., Wong Y.P., Ng E.K., Yu J., Leung W.K., Sung J.J., Chan F.K. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer. Br. J. Cancer 2008, 99:2083-2087.
37. Kanda M., Nomoto S., Okamura Y., Hayashi M., Hishida M., Fujii T., Nishikawa Y., Sugimoto H., Takeda S., Nakao A. Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma. Mol. Carcinog. 2011, 50:571-579.
38. Lee N.V., Rodriguez-Manzaneque J.C., Thai S.N., Twal W.O., Luque A., Lyons K.M., Argraves W.S., Iruela-Arispe M.L. Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. J. Biol. Chem. 2005, 280:34796-34804.
39. Cal S., Obaya A.J., Llamazares M., Garabaya C., Quesada V., Lopez-Otin C. Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. Gene 2002, 283:49-62.
40. Moncada-Pazos A., Obaya A.J., Fraga M.F., Viloria C.G., Capella G., Gausachs M., Esteller M., Lopez-Otin C., Cal S. The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer. J. Cell Sci. 2009, 122:2906-2913.
41. Viloria C.G., Obaya A.J., Moncada-Pazos A., Llamazares M., Astudillo A., Capella G., Cal S., Lopez-Otin C. Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer. Cancer Res. 2009, 69:4926-4934.
42. Vazquez F., Hastings G., Ortega M.A., Lane T.F., Oikemus S., Lombardo M., Iruela-Arispe M.L. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J. Biol. Chem. 1999, 274:23349-23357.
43. Kuno K., Bannai K., Hakozaki M., Matsushima K., Hirose K. The carboxyl-terminal half region of ADAMTS-1 suppresses both tumorigenicity and experimental tumor metastatic potential. Biochem. Biophys. Res. Commun. 2004, 319:1327-1333.
44. Luque A., Carpizo D.R., Iruela-Arispe M.L. ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J. Biol. Chem. 2003, 278:23656-23665.
45. Rocks N., Paulissen G., Quesada-Calvo F., Munaut C., Gonzalez M.L., Gueders M., Hacha J., Gilles C., Foidart J.M., Noel A., Cataldo D.D. ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo. Cancer Res. 2008, 68:9541-9550.
46. Lee N.V., Sato M., Annis D.S., Loo J.A., Wu L., Mosher D.F., Iruela-Arispe M.L. ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J. 2006, 25:5270-5283.
47. Lee Y.J., Koch M., Karl D., Torres-Collado A.X., Fernando N.T., Rothrock C., Kuruppu D., Ryeom S., Iruela-Arispe M.L., Yoon S.S. Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1. Cancer Res. 2010, 70:948-956.
48. Ricciardelli C., Frewin K.M., Tan Ide A., Williams E.D., Opeskin K., Pritchard M.A., Ingman W.V., Russell D.L. The ADAMTS1 protease gene is required for mammary tumor growth and metastasis. Am. J. Pathol. 2011, 179:3075-3085.
49. Fu Y., Nagy J.A., Brown L.F., Shih S.C., Johnson P.Y., Chan C.K., Dvorak H.F., Wight T.N. Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A/VPF-induced pathological angiogenesis. J. Histochem. Cytochem. 2011, 59:463-473.
50. Kern C.B., Twal W.O., Mjaatvedt C.H., Fairey S.E., Toole B.P., Iruela-Arispe M.L., Argraves W.S. Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev. Dyn. 2006, 235:2238-2247.
51. Cooley M.A., Fresco V.M., Dorlon M.E., Twal W.O., Lee N.V., Barth J.L., Kern C.B., Iruela-Arispe M.L., Argraves W.S. Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation. Dev. Dyn. 2012, 241:303-314.
52. Ramaswamy S., Ross K.N., Lander E.S., Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 2003, 33:49-54.
53. Senapati S., Gnanapragassam V.S., Moniaux N., Momi N., Batra S.K. Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells. Oncogene 2011.
54. Whiteaker J.R., Zhang H., Zhao L., Wang P., Kelly-Spratt K.S., Ivey R.G., Piening B.D., Feng L.C., Kasarda E., Gurley K.E., Eng J.K., Chodosh L.A., Kemp C.J., McIntosh M.W., Paulovich A.G. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. J. Proteome Res. 2007, 6:3962-3975.
55. Yi C.H., Smith D.J., West W.W., Hollingsworth M.A. Loss of fibulin-2 expression is associated with breast cancer progression. Am. J. Pathol. 2007, 170:1535-1545.
56. Alcendor D.J., Knobel S., Desai P., Zhu W.Q., Hayward G.S. KSHV regulation of fibulin-2 in Kaposi's sarcoma: implications for tumorigenesis. Am. J. Pathol. 2011, 179:1443-1454.
57. Dunwell T.L., Hesson L.B., Pavlova T., Zabarovska V., Kashuba V., Catchpoole D., Chiaramonte R., Brini A.T., Griffiths M., Maher E.R., Zabarovsky E., Latif F. Epigenetic analysis of childhood acute lymphoblastic leukemia. Epigenetics 2009, 4:185-193.
58. Hu B., Thirtamara-Rajamani K.K., Sim H., Viapiano M.S. Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion. Mol. Cancer Res. 2009, 7:1756-1770.
59. Seeliger H., Camaj P., Ischenko I., Kleespies A., De Toni E.N., Thieme S.E., Blum H., Assmann G., Jauch K.W., Bruns C.J. EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma. Mol. Cancer Res. 2009, 7:189-198.
60. Camaj P., Seeliger H., Ischenko I., Krebs S., Blum H., De Toni E.N., Faktorova D., Jauch K.W., Bruns C.J. EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells. Biol. Chem. 2009, 390:1293-1302.
61. Albig A.R., Neil J.R., Schiemann W.P. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res. 2006, 66:2621-2629.
62. Hwang C.F., Chien C.Y., Huang S.C., Yin Y.F., Huang C.C., Fang F.M., Tsai H.T., Su L.J., Chen C.H. Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity. J. Pathol. 2010, 222:367-379.
63. Sadr-Nabavi A., Ramser J., Volkmann J., Naehrig J., Wiesmann F., Betz B., Hellebrand H., Engert S., Seitz S., Kreutzfeld R., Sasaki T., Arnold N., Schmutzler R., Kiechle M., Niederacher D., Harbeck N., Dahl E., Meindl A. Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int. J. Cancer 2009, 124:1727-1735.
64. Nomoto S., Kanda M., Okamura Y., Nishikawa Y., Qiyong L., Fujii T., Sugimoto H., Takeda S., Nakao A. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Ann. Surg. Oncol. 2010, 17:923-932.
65. Tong J.D., Jiao N.L., Wang Y.X., Zhang Y.W., Han F. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis. Neoplasma 2011, 58:441-448.
66. Gallagher W.M., Argentini M., Sierra V., Bracco L., Debussche L., Conseiller E. MBP1: a novel mutant p53-specific protein partner with oncogenic properties. Oncogene 1999, 18:3608-3616.
67. Gallagher W.M., Greene L.M., Ryan M.P., Sierra V., Berger A., Laurent-Puig P., Conseiller E. Human fibulin-4: analysis of its biosynthetic processing and mRNA expression in normal and tumour tissues. FEBS Lett. 2001, 489:59-66.
68. Colas E., Perez C., Cabrera S., Pedrola N., Monge M., Castellvi J., Eyzaguirre F., Gregorio J., Ruiz A., Llaurado M., Rigau M., Garcia M., Ertekin T., Montes M., Lopez-Lopez R., Carreras R., Xercavins J., Ortega A., Maes T., Rosell E., Doll A., Abal M., Reventos J., Gil-Moreno A. Molecular markers of endometrial carcinoma detected in uterine aspirates. Int. J. Cancer 2011, 129:2435-2444.
69. Wlazlinski A., Engers R., Hoffmann M.J., Hader C., Jung V., Muller M., Schulz W.A. Downregulation of several fibulin genes in prostate cancer. Prostate 2007, 67:1770-1780.
70. Schiemann W.P., Blobe G.C., Kalume D.E., Pandey A., Lodish H.F. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J. Biol. Chem. 2002, 277:27367-27377.
71. Lee Y.H., Albig A.R., Regner M., Schiemann B.J., Schiemann W.P. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Carcinogenesis 2008, 29:2243-2251.
72. Ohara H., Akatsuka S., Nagai H., Liu Y.T., Jiang L., Okazaki Y., Yamashita Y., Nakamura T., Toyokuni S. Stage-specific roles of fibulin-5 during oxidative stress-induced renal carcinogenesis in rats. Free Radic. Res. 2011, 45:211-220.
73. Schluterman M.K., Chapman S.L., Korpanty G., Ozumi K., Fukai T., Yanagisawa H., Brekken R.A. Loss of fibulin-5 binding to beta1 integrins inhibits tumor growth by increasing the level of ROS. Dis. Model. Mech. 2010, 3:333-342.
74. Moller H.D., Ralfkjaer U., Cremers N., Frankel M., Pedersen R.T., Klingelhofer J., Yanagisawa H., Grigorian M., Guldberg P., Sleeman J., Lukanidin E., Ambartsumian N. Role of fibulin-5 in metastatic organ colonization. Mol. Cancer Res. 2011, 9:553-563.
75. Albig A.R., Schiemann W.P. Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol. 2004, 23:367-379.
76. Sullivan K.M., Bissonnette R., Yanagisawa H., Hussain S.N., Davis E.C. Fibulin-5 functions as an endogenous angiogenesis inhibitor. Lab. Invest. 2007, 87:818-827.
77. Kuang P.P., Joyce-Brady M., Zhang X.H., Jean J.C., Goldstein R.H. Fibulin-5 gene expression in human lung fibroblasts is regulated by TGF-beta and phosphatidylinositol 3-kinase activity. Am. J. Physiol. Cell Physiol. 2006, 291:C1412-1421.
78. Preis M., Cohen T., Sarnatzki Y., Ben Yosef Y., Schneiderman J., Gluzman Z., Koren B., Lewis B.S., Shaul Y., Flugelman M.Y. Effects of fibulin-5 on attachment, adhesion, and proliferation of primary human endothelial cells. Biochem. Biophys. Res. Commun. 2006, 348:1024-1033.
79. Pos Z., Wiener Z., Pocza P., Racz M., Toth S., Darvas Z., Molnar V., Hegyesi H., Falus A. Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma. Cancer Res. 2008, 68:1997-2005.
80. Kapustin A., Stepanova V., Aniol N., Cines D.B., Poliakov A., Yarovoi S., Lebedeva T., Wait R., Ryzhakov G., Parfyonova Y., Gursky Y., Yanagisawa H., Minashkin M., Beabealashvilli R., Vorotnikov A., Bobik A., Tkachuk V. Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated beta1-integrin-dependent cell migration. Biochem J. 2012, 443:491-503.
81. Schindler A.J., Sherwood D.R. The transcription factor HLH-2/E/Daughterless regulates anchor cell invasion across basement membrane in C. elegans. Dev. Biol. 2011, 357:380-391.
82. Xu X., Vogel B.E. A secreted protein promotes cleavage furrow maturation during cytokinesis. Curr. Biol. 2011, 21:114-119.
83. Arany S., Koyota S., Sugiyama T. Nerve growth factor promotes differentiation of odontoblast-like cells. J. Cell. Biochem. 2009, 106:539-545.
84. Folgueras A.R., Pendas A.M., Sanchez L.M., Lopez-Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int. J. Dev. Biol. 2004, 48:411-424.
85. Horiguchi M., Inoue T., Ohbayashi T., Hirai M., Noda K., Marmorstein L.Y., Yabe D., Takagi K., Akama T.O., Kita T., Kimura T., Nakamura T. Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase. Proc. Natl. Acad. Sci. USA 2009, 106:19029-19034.